Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
- Last Action
- 6/8/2021
Actions
- 2021-06-08Read twice and referred to the Committee on Finance.
- 2021-06-08Introduced in Senate
CRS Summary
As of 2021-06-08 (00)
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease.
Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.
Cosponsors (1)
- Roy Blunt (R-MO)
Subjects
- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug therapy
- Government studies and investigations
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health facilities and institutions
- Health promotion and preventive care
- Health technology, devices, supplies
- Medicaid
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Minority health
- Organ and tissue donation and transplantation
- State and local government operations
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.